Five years after a stem cell transplant with the same critical factor as those received by the Berlin patient and the London patient, and four months after stopping antiretroviral treatment, a Düsseldorf man remains virally suppressed SEATTLE – Exemplifying both the caution and the optimism essential to HIV cure science, Dr. Björn-Erik Ole Jensen won’t […]
SEATTLE – If you’re counting those in lasting remission from HIV, Dr. John Mellors of the University of Pittsburgh said here today, there’s been a doubling in their numbers. Now there are two. The dry tone of Mellor’s remarks, and the circumspect wording of Dr. Ravindra Gupta, the physician researcher of University College London, who he […]
What happened to Timothy Brown was almost serendipitous, coming as it did from a combination of knowledge, opportunity and readiness. Although what he went through nearly killed him, he remains singularly fortunate. Today, after a year of disappointing news from some on the front lines of HIV cure research, the information gleaned from his case […]
Ambassador Deborah Birx, Anthony Fauci, Michel Sidibe, Kenneth Cole, Miss Universe, Rep. Nancy Pelosi, Sen. Tom Harkin, and World Bank President Jim Kim among participants in event to “Make AIDS History.” It already sounds like history now, before testing, before treatment, before activism, science, money and policy introduced hope into the time when an AIDS […]
Science Speaks is in Atlanta, Georgia this week and will be live-blogging from the 20th CROI — Conference on Retroviruses and Opportunistic Infections from Sunday to Wednesday, covering breaking developments from investigators on cure research, new antiretroviral agents, hepatitis, tuberculosis and treatment as prevention. ATLANTA, GA — To put this in perspective, about 70 million […]
HIV
The following is a guest post by Mitchell Warren of AVAC This year’s annual HIV Vaccine Awareness Day arrives Saturday at a promising and also perilous […]
Tuberculosis
In sub-Saharan Africa where the odds of dying within a year of starting treatment for HIV can still hover close to one-in-10, diagnosing and treating TB […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The following is a guest post by Heather B. Davis, MPH, and Emily A. Bobrow, PhD, MPH, of MEASURE Evaluation Who has a strategic interest in […]